Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05656365 · ClinicalTrials.gov registry record

Evaluating the Genetics and Immunology of Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome and Other Tonsil Disorders

A clinical trial of Obstructive Sleep Apnea and Sleep Disordered Breathing, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

Recruiting
Registry status
1,500
Enrollment target
3
Study locations

NCT05656365 is a study of Obstructive Sleep Apnea and Sleep Disordered Breathing that is actively recruiting participants, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 1,500 participants, above the 212-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (608% higher). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05656365, a study of Obstructive Sleep Apnea and Sleep Disordered Breathing, is actively recruiting participants, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

RECRUITING
Registry status
1,500 participants
Enrollment target
3
Study locations

Study Summary

Background: Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) is the most common periodic fever syndrome of childhood. Symptoms can include swelling of the glands in the throat, mouth ulcers, and tonsillitis. Removal of the tonsils can stop the periodic flareups. But researchers do not know how PFAPA develops. In this natural history study, researchers will collect specimens and data from people with PFAPA to see what they might have in common. Objective: To collect blood and other specimens from people with PFAPA to learn more about the illness. Eligibility: People aged 1 month or older with symptoms of PFAPA or another tonsil disorder. Design: Participants will be screened. Their medical records will be reviewed. Researchers will ask about a family history of PFAPA. The following specimens may be collected: Blood. Blood will be drawn either from a needle inserted into a vein or from a prick in the finger or heel. Mucus and cells. A stick with soft padding on the tip may be rubbed inside the nostrils or mouth. Stool. Saliva. Tissue samples may be taken if participants are having surgery to remove the tonsils or adenoids. Participants having surgery may also have a nasopharyngeal wash; salt water will be squirted into the back of the throat and then sucked back out with a syringe. Most participants will provide specimens only once. They can do this in person at the clinic; they can also have their local health providers send specimens to the researchers. Some participants may have optional follow-up visits over 10 years.

Study Locations (3)

District of Columbia

  • Children's National Medical Center - Washington D.C.

Indiana

  • Indiana University School of Medicine - Indianapolis

Maryland

  • National Institutes of Health Clinical Center - Bethesda

Trial Details

FieldValue
Enrollment Target 1,500 participants
Start Date 2023-05-23
Est. Completion 2038-12-31

What the Registry Record Tells You About NCT05656365

The ClinicalTrials.gov registry entry for NCT05656365 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 212-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (608% higher). The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 0 interventions.

NCT05656365 reports 3 study locations spanning 3 distinct geographic areas - top geographies include District of Columbia, Indiana, Maryland.

Frequently Asked Questions

What is clinical trial NCT05656365 about?

NCT05656365 is a clinical study titled "Evaluating the Genetics and Immunology of Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome and Other Tonsil Disorders". Background: Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) is the most common periodic fever syndrome of childhood. Symptoms can include swelling of the glands in the throat, mouth ulcers, and tonsillitis. Removal of the tonsils can stop the periodic flareups. But r...

What is the current status of trial NCT05656365?

This trial is currently recruiting. The enrollment target is 1,500 participants. The study started on 2023-05-23. Estimated completion is 2038-12-31.

What conditions does trial NCT05656365 study?

This clinical trial studies the following conditions: Obstructive Sleep Apnea, Sleep Disordered Breathing, Tonsillitis, Periodic Fever, Aphthous Stomatitis, Pharyngitis, And Cervical Adenitis (Pfapa), Tonsil Disorder.

Who is sponsoring clinical trial NCT05656365?

This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05656365 being conducted?

This trial has 3 study locations across District of Columbia, Indiana, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obstructive Sleep Apnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.